Skip to content
lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cardiff Oncology, Inc.
Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
April 29, 2026
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
April 25, 2026
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
January 27, 2026
Cardiff Oncology Announces Positive Update from its Randomized Phase 2 Trial of Onvansertib in First-line RAS-mutated mCRC
January 27, 2026
←
Previous Page
1
2